Renaissance Capital logo

180 Life Sciences (KBL Merger Corp. IV) Priced, Nasdaq: ATNF

Blank check company formed by Dr. Marlene Krauss of KBL Healthcare Ventures (completed 11/9/2020).

Industry: SPAC

First Day Return: 0.0%

Industry: SPAC

We are a blank check company organized under the laws of the State of Delaware on September 7, 2016. We were formed for the purpose of effecting a merger, capital stock exchange, stock purchase, asset acquisition or other similar business combination with one or more operating businesses, which we refer throughout this prospectus as our initial business combination. We intend to focus our efforts on acquiring an operating company in the healthcare and related wellness industry although our efforts in identifying a prospective target business will not be limited to a particular industry. We have not identified any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with respect to identifying any business combination target.
more less
IPO Data
IPO File Date 04/26/2017
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 10.0
Deal Size ($mm) $100
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 06/01/2017
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $100
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Newark, DE, United States
Founded 2016
Employees at IPO 2
Website www.kblhealthcare.com

180 Life Sciences (KBL Merger Corp. IV) (ATNF) Performance